Lombard Odier Asset Management (USA)’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-20,198	Closed	-$1.71M	–	223
2018 Q4	$1.71M	Buy	+20,198	New	+$1.71M	0.13%	100